Medical - Specialties industry analysis: EL7 Score and the best stocks ranked by value, profitability, and momentum.
Ranked among 5 stocks with a market cap above $500M. Smaller companies are excluded from the ranking.
Rank | Company | Price | P/E | Value | Growth | Quality | EL7 Score |
|---|---|---|---|---|---|---|---|
| 1/5 | ![]() | $13.93 | 30.3 | 48 | 100 | 91 | 96 |
| 2/5 | ![]() | $120.87 | 142.2 | 64 | 60 | 87 | 88 |
| 3/5 | ![]() | $210.76 | 25.7 | 80 | 64 | 70 | 76 |
| 4/5 | ![]() | $66.03 | 50.8 | 60 | 52 | 78 | 72 |
| 5/5 | ![]() | $11.78 | — | 88 | 12 | 35 | 8 |
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
108 of 151
P/E 30.3 vs period average 31.2 Near its historical average
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Insider purchases in the sector's stocks
Funds that track the sector and each fund's exposure to it.
Fund | Exposure | Assets | Expense |
|---|---|---|---|
| IBBiShares Biotechnology ETF | 100.0% | $10B | 0.44% |
| VHTVanguard Health Care ETF | 100.0% | $21B | 0.09% |
| IHIiShares U.S. Medical Devices ETF | 99.7% | $3B | 0.37% |
| XLVState Street Health Care Select Sector SPDR ETF | 99.2% | $43B | 0.08% |
The percentage is the sector's share of the fund's assets, per the latest available data.
Upgrades and downgrades on the sector's stocks